7/n Catherine Maitre DG FranceBiotech rappelle qu’en moyenne le développement d’un nouveau médicament dure 15 ans et coûte 2Md€.
May 18, 2026 at 5:30 PM
7/n Catherine Maitre DG FranceBiotech rappelle qu’en moyenne le développement d’un nouveau médicament dure 15 ans et coûte 2Md€.
France intensifies the war on cancer with precision immunotherapies. 🧬🛡️
#OncoTech #Immunotherapy #FranceBiotech #CancerResearch
www.marketresearchfuture.com/reports/fran...
#OncoTech #Immunotherapy #FranceBiotech #CancerResearch
www.marketresearchfuture.com/reports/fran...
France Cancer Immunotherapy Market Size, Growth Outlook 2035
France Cancer Immunotherapy Market projected to grow at 4.889% CAGR, reaching USD 6.05 Billion by 2035, driving growth global trends, competitive industry analysis and outlook 2025-2035.
www.marketresearchfuture.com
June 16, 2025 at 5:31 AM
France intensifies the war on cancer with precision immunotherapies. 🧬🛡️
#OncoTech #Immunotherapy #FranceBiotech #CancerResearch
www.marketresearchfuture.com/reports/fran...
#OncoTech #Immunotherapy #FranceBiotech #CancerResearch
www.marketresearchfuture.com/reports/fran...